MTOR and prostate carcinoma: Li et al[51] research revealed that FBP1 knockdown in prostate cancer could activate autophagy mediated by the AMPK-mTOR signaling pathway, while inhibition of the AMPK-mTOR signaling pathway could reverse FBP1 knockdown-mediated autophagy and apoptosis.